Cross-talk between EZH2 and NF-kB in breast cancers.
Epigenetic changes are reported to contribute to cancer progression. EZH2 is the catalytic component of PRC2 and its SET domain is involved in histone methyltransferase activity, to silence specific genes in cancer progression. Although EZH2 SET domain independent functions have been reported recent...
Saved in:
Main Author: | Ong, Sandy Li Ya. |
---|---|
Other Authors: | School of Biological Sciences |
Format: | Final Year Project |
Language: | English |
Published: |
2010
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/38681 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
EZH2 and NF-KB Crosstalk in Breast Cancer
by: LEE SHUET THENG
Published: (2012) -
Enterococcus faecalis modulation of NF-kB signaling in macrophages
by: Tagore, Soumili Bhaduri
Published: (2016) -
Context-Specific Regulation of NF-κB Target Gene Expression by EZH2 in Breast Cancers
by: Lee, S.T., et al.
Published: (2014) -
Involvement of NF-kB in normal and thalassemic erythropoiesis
by: Nattaya Sae-Ung
Published: (2023) -
Regulation of NOD2-dependent NF-kB signaling by tumour suppressor network.
by: Suhendra.
Published: (2011)